London Company of Virginia’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.27M | Hold |
37,453
| – | – | 0.01% | 122 |
|
|
2025
Q4 | $2.02M | Sell |
37,453
-787
| -2% | -$37.9K | 0.01% | 134 |
|
|
2025
Q3 | $1.72M | Sell |
38,240
-7,506
| -16% | -$351K | 0.01% | 134 |
|
|
2025
Q2 | $2.12M | Hold |
45,746
| – | – | 0.01% | 127 |
|
|
2025
Q1 | $2.79M | Sell |
45,746
-1,915
| -4% | -$112K | 0.02% | 128 |
|
|
2024
Q4 | $2.7M | Sell |
47,661
-3,545
| -7% | -$198K | 0.01% | 130 |
|
|
2024
Q3 | $2.65M | Sell |
51,206
-21,886
| -30% | -$1.03M | 0.01% | 129 |
|
|
2024
Q2 | $3.04M | Sell |
73,092
-10,948
| -13% | -$490K | 0.02% | 130 |
|
|
2024
Q1 | $4.56M | Buy |
84,040
+3,564
| +4% | +$182K | 0.02% | 127 |
|
|
2023
Q4 | $4.13M | Sell |
80,476
-3,776
| -4% | -$198K | 0.02% | 125 |
|
|
2023
Q3 | $4.89M | Sell |
84,252
-21,660
| -20% | -$1.33M | 0.03% | 122 |
|
|
2023
Q2 | $6.77M | Sell |
105,912
-587
| -0.6% | -$39.4K | 0.04% | 113 |
|
|
2023
Q1 | $7.38M | Sell |
106,499
-5,897
| -5% | -$416K | 0.04% | 113 |
|
|
2022
Q4 | $8.09M | Hold |
112,396
| – | – | 0.05% | 113 |
|
|
2022
Q3 | $7.99M | Sell |
112,396
-3,597
| -3% | -$261K | 0.05% | 112 |
|
|
2022
Q2 | $8.93M | Sell |
115,993
-1,484
| -1% | -$113K | 0.05% | 113 |
|
|
2022
Q1 | $8.58M | Sell |
117,477
-162
| -0.1% | -$10.9K | 0.05% | 113 |
|
|
2021
Q4 | $7.33M | Sell |
117,639
-82,954
| -41% | -$4.87M | 0.04% | 112 |
|
|
2021
Q3 | $11.9M | Sell |
200,593
-492,593
| -71% | -$32.4M | 0.07% | 104 |
|
|
2021
Q2 | $46.3M | Buy |
693,186
+7,578
| +1% | +$494K | 0.25% | 79 |
|
|
2021
Q1 | $43.3M | Buy |
685,608
+5,305
| +0.8% | +$330K | 0.25% | 79 |
|
|
2020
Q4 | $42.2M | Buy |
680,303
+5,414
| +0.8% | +$333K | 0.26% | 76 |
|
|
2020
Q3 | $40.7M | Sell |
674,889
-6,788
| -1% | -$409K | 0.29% | 73 |
|
|
2020
Q2 | $40.1M | Buy |
681,677
+3,291
| +0.5% | +$197K | 0.31% | 70 |
|
|
2020
Q1 | $37.8M | Buy |
678,386
+4,023
| +0.6% | +$246K | 0.36% | 70 |
|
|
2019
Q4 | $43.3M | Sell |
674,363
-20,413
| -3% | -$1.17M | 0.33% | 77 |
|
|
2019
Q3 | $35.2M | Sell |
694,776
-30,733
| -4% | -$1.44M | 0.29% | 77 |
|
|
2019
Q2 | $32.9M | Sell |
725,509
-155,407
| -18% | -$7.24M | 0.28% | 81 |
|
|
2019
Q1 | $42M | Buy |
880,916
+6,352
| +0.7% | +$316K | 0.36% | 74 |
|
|
2018
Q4 | $45.5M | Sell |
874,564
-47,891
| -5% | -$2.57M | 0.43% | 63 |
|
|
2018
Q3 | $57.3M | Sell |
922,455
-31,837
| -3% | -$1.89M | 0.45% | 63 |
|
|
2018
Q2 | $52.8M | Sell |
954,292
-45,315
| -5% | -$2.45M | 0.43% | 65 |
|
|
2018
Q1 | $63.2M | Sell |
999,607
-1,944
| -0.2% | -$125K | 0.51% | 59 |
|
|
2017
Q4 | $61.4M | Sell |
1,001,551
-18,925
| -2% | -$1.18M | 0.44% | 63 |
|
|
2017
Q3 | $65M | Sell |
1,020,476
-40,707
| -4% | -$2.38M | 0.47% | 64 |
|
|
2017
Q2 | $59.1M | Sell |
1,061,183
-64,780
| -6% | -$3.53M | 0.4% | 73 |
|
|
2017
Q1 | $61.2M | Sell |
1,125,963
-33,109
| -3% | -$1.82M | 0.4% | 73 |
|
|
2016
Q4 | $67.7M | Sell |
1,159,072
-90,418
| -7% | -$4.94M | 0.47% | 70 |
|
|
2016
Q3 | $67.4M | Buy |
1,249,490
+36,124
| +3% | +$2.32M | 0.5% | 71 |
|
|
2016
Q2 | $89.2M | Sell |
1,213,366
-9,748
| -0.8% | -$689K | 0.69% | 61 |
|
|
2016
Q1 | $78.1M | Sell |
1,223,114
-2,388,893
| -66% | -$151M | 0.64% | 60 |
|
|
2015
Q4 | $248M | Buy |
3,612,007
+479,003
| +15% | +$31.7M | 2.15% | 11 |
|
|
2015
Q3 | $185M | Buy |
3,133,004
+115,802
| +4% | +$7.35M | 1.72% | 17 |
|
|
2015
Q2 | $201M | Buy |
3,017,202
+398,849
| +15% | +$26.3M | 1.74% | 16 |
|
|
2015
Q1 | $169M | Buy |
2,618,353
+301,806
| +13% | +$18.9M | 1.55% | 23 |
|
|
2014
Q4 | $137M | Buy |
2,316,547
+222,344
| +11% | +$12.5M | 1.43% | 24 |
|
|
2014
Q3 | $107M | Buy |
2,094,203
+51,360
| +3% | +$2.57M | 1.2% | 32 |
|
|
2014
Q2 | $99.1M | Buy |
2,042,843
+122,950
| +6% | +$6.06M | 1.08% | 36 |
|
|
2014
Q1 | $99.7M | Sell |
1,919,893
-285,982
| -13% | -$15.2M | 1.12% | 34 |
|
|
2013
Q4 | $117M | Buy |
2,205,875
+321,632
| +17% | +$16.4M | 1.34% | 25 |
|
|
2013
Q3 | $87.2M | Buy |
1,884,243
+111,750
| +6% | +$4.91M | 1.19% | 29 |
|
|
2013
Q2 | $79.2M | Buy |
+1,772,493
| New | +$77M | 1.15% | 29 |
|
Other funds holding BMY
VCM
VPM
London Company of Virginia's BMY Position: Q1 2026 in Review
London Company of Virginia held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 37,453 shares worth $2.27M. The position accounts for 0.01% of the portfolio, ranked #122.
London Company of Virginia first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $248M in Q4 2015. 2,528 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- London Company of Virginia held 37,453 shares of Bristol-Myers Squibb worth $2.27M as of Q1 2026.
- London Company of Virginia left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 0.01% of London Company of Virginia's portfolio in Q1 2026, its #122 holding.
- London Company of Virginia first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- London Company of Virginia's Bristol-Myers Squibb position peaked at $248M in Q4 2015.
- 2,528 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on London Company of Virginia's 13F filing for Q1 2026, filed 15 May 2026.